Latest Hemodialysis News
Study links the pain relievers to altered mental status, fall, and fracture.
Older patients who had more frequent nephrology visits prior to initiating dialysis had a lower incidence of atrial fibrillation in the year after initiating dialysis compared with those who did not.
A serum phosphate control target of 4.5 mg/dL or below in hemodialysis patients was accompanied by a decline in fibroblast growth factor 23.
In a prospective study, aspirin users were more likely to have a successful outcome following PTA for venous stenoses in arteriovenous fistulas or grafts.
Control of parathyroid hormone did not differ markedly at 48 and 72 hours after in-center HD compared with 24 hours after daily oral administration of 30 mg cinacalcet.
Mean 25-hydroxyvitamin D levels did not differ significantly among groups receiving phosphate binders or dietary therapy.
In a survey, nearly one-third of hemodialysis patients said they disliked fluid restriction.
Study of 109,501 incidental HD patients reveals an association between high mean corpuscular volume and increased risk of all-cause, cardiovascular, and infection-related mortality.
Prospective study reveals that patients on hemodialysis whose blood selenium concentrations are in the lowest decile have a 3.4-fold higher odds of death.
In a study, the 30-day readmission rate for hemodialysis patients hospitalized for cardiovascular events was 34.2%.
Global CBF declined significantly by 10% from before the start to the end of hemodialysis.
Fresenius Medical Care North America has promoted Ahmad Sharif, MD, MPH, to Chief Medical Information Officer for North America.
Patients with the highest levels of serum alkaline phosphatase were more likely to die from infections and cardiovascular causes.
In hemodialysis patients, only non-traditional risk factors such as C-reactive protein predicted non-fatal myocardial infarction and other atherosclerotic events, researchers report.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)